T2* MRI Analysis for Sarcoma
| Status: | Recruiting |
|---|---|
| Conditions: | Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 12/12/2018 |
| Start Date: | September 18, 2018 |
| End Date: | December 31, 2021 |
| Contact: | Bryan G. Allen, MD, PhD |
| Email: | bryan-allen@uiowa.edu |
| Phone: | (319) 356-3693 |
An Exploratory, Pilot Study Evaluating T2* Imaging for Adult Sarcoma
T2* imaging is a method to identify labile iron pools in tumor cells. These iron pools may be
linked to better treatment outcomes for specific types of therapy. This is a small pilot
study to see if radiation therapy changes the amount of iron in a sarcoma tumor.
linked to better treatment outcomes for specific types of therapy. This is a small pilot
study to see if radiation therapy changes the amount of iron in a sarcoma tumor.
Inclusion Criteria:
- pathologically confirmed Sarcoma, by biopsy or excision
- prescribed radiation therapy as per standard of care
- treatment to begin within 5 weeks after surgery or biopsy
- ECOG 0, 1, or 2
- ability and willingness to provide informed consent
Exclusion Criteria:
- < 18 years of age
We found this trial at
1
site
Iowa City, Iowa 52242
Principal Investigator: Bryan Allen, MD, PhD
Phone: 319-353-7143
Click here to add this to my saved trials
